cell therapy
Despite Overall Survival Miss, Singapore Researchers Champion Success of Global Cell Therapy Trial
Premium
The global Phase III VANCE trial of the autologous EBV-targeted T-cell therapy was the largest trial of a solid tumor cell therapy to date.
The firm is also studying PTG-007 in patients with early-stage type 1 diabetes, but is looking for a partner for the pivotal trial.
AstraZeneca Selects Diabetes Treg Cell Therapy Triggering $10M Payout for Quell Therapeutics
AstraZeneca will take the chosen type 1 diabetes product into preclinical and clinical studies and Quell will provide manufacturing support.
Giostar Gearing up for Phase II Trial of Type 2 Diabetes Stem Cell Therapy in US
The FDA has cleared the research organization's investigational new drug application, allowing it to start clinical tests of the experimental treatment DT2-SCT.
In Brief This Week: MD Anderson, Genascence, Seattle Children's Hospital, Abeona, Mount Sinai
News items for the week of Nov. 11, 2024.
Nov 15, 2024
Oct 11, 2024
Immatics Prices $150M Stock Offering
Oct 11, 2024
Oct 10, 2024